Who
Adam Logal
Sr. Vice President, CFO
Company insider
Files Form 4 as: Sr. Vice President, CFO, Opko Health; Director, Xenetic Biosciences; Director, VBI Vaccines Inc/BC; Interim CFO, CAO and Treasurer, Vaxart.
In numbers
- Trades disclosed
- 99
- Buys
- 4
- Sells
- 10
- Bought
- $33K
- Sold
- $2.2M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 12 May 2006
- Last trade
- 24 Jul 2026
- Last filed
- 28 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jul 2026filed 28 Jul 2026 | OPK Opko HealthBiotechnology | SEC FORM 4 Code F | $65K53,266 at $1.22 | filing |
| 24 Jul 2026filed 28 Jul 2026 | OPK Opko HealthBiotechnology | SEC FORM 4 Code F | $65K53,266 at $1.22 | filing |
| 27 May 2025filed 29 May 2025 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —437,500 at $0.00 | filing |
| 24 Jul 2024filed 26 Jul 2024 | OPK Opko HealthBiotechnology | SEC FORM 4 Code A | —437,500 at $0.00 | filing |
| 6 Dec 2023filed 8 Dec 2023 | XBIO Xenetic Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 18 May 2023filed 19 May 2023 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —700,000 at $0.00 | filing |
| 7 Dec 2022filed 9 Dec 2022 | XBIO Xenetic Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 7 Dec 2021filed 9 Dec 2021 | XBIO Xenetic Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 19 Feb 2021filed 22 Feb 2021 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 4 Dec 2020filed 8 Dec 2020 | XBIO Xenetic Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 4 Jun 2020filed 8 Jun 2020 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 4 Dec 2019filed 6 Dec 2019 | XBIO Xenetic Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Jul 2019filed 3 Jul 2019 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 9 May 2019filed 10 May 2019 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $204100 at $2.04 | filing |
| 9 May 2019filed 10 May 2019 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $6,4263,150 at $2.04 | filing |
| 28 Nov 2018filed 30 Nov 2018 | XBIO Xenetic Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 21 Jun 2018filed 22 Jun 2018 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 14 Jun 2018filed 18 Jun 2018 | VBI Vaccines Inc/BCoption or derivative | SEC FORM 4 Code M | —12,500 | filing |
| 14 Jun 2018filed 18 Jun 2018 | VBI Vaccines Inc/BC | SEC FORM 4 Code M | —12,500 | filing |
| 8 Jun 2018filed 12 Jun 2018 | OPK Opko HealthBiotechnology | SEC FORM 4 Code M | $257K75,000 at $3.43 | filing |
News
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthOPK · prnewswire.com · 15 Oct 2026
0 headlines in the last 90 days name Adam Logal; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.